The 2 Minute Medicine® Podcast- Episode 18

The 2 Minute Medicine® Podcast- Episode 18

Up next

The 2 Minute Medicine® Podcast- One-Dose HPV Vaccines, Oral Semaglutide, AI Deepfake Doctors, and Longevity Tech from CES 2026

In this episode, we lead with our article of the week from the New England Journal of Medicine examining the noninferiority of a single-dose HPV vaccine compared with the standard two-dose regimen. We then dive into a detailed edition of The Scan, discussing how oral semaglutide ...  Show more

The 2 Minute Medicine® Podcast- Pharma Roundup 10/15

In this episode of the 2 Minute Medicine Podcast: Pharma Roundup, we explore how innovation, regulation, and global strategy are reshaping the pharmaceutical landscape. We begin with the FDA’s approval of Enbumyst, the first intranasal loop diuretic for edema, offering patients w ...  Show more

Recommended Episodes

TMHS 532: New Vaccine Safety Data & World Health Status Update
The Model Health Show

There are many issues that can spark a heated controversy in the US, one of them being our for-profit healthcare system. Each year, our country spends $4 trillion on healthcare, yet we’re sicker than ever. When you go to the doctor with a symptom, you’ll most likely walk out of t ...  Show more

Episode 77: Analyzing Rising Healthcare Costs in the US: the Role of Palliative Care and Advocacy
The Lebanese Physicians' Podcast

Please listen to and watch this latest episode of The Lebanese Physicians' Podcast with Dr. Lama El Zein MD, MHA. Dr. El Zein just started a position as Vice President, Quality and Implementation Science at Hackensack Meridian Health in New Jersey.

In this episode, we d ...

  Show more

Nov 4, 2022 This Week in Cardiology Podcast
This Week in Cardiology

AF conversion in the ED, HRT, a shining example of evidence-based medicine and less-is-more, multimorbidity, and what's coming at AHA are the topics John Mandrola, MD, covers in this week's podcast. This podcast is intended for healthcare professionals only. <u>To rea ...

  Show more

The Promise of a New Treatment
Prognosis: Misconception

The drug company Eli Lilly is about to start testing its Covid-19 antibody drug in nursing homes. Vaccines may not work as well on elderly people or those with compromised immune systems. Since these are the very groups most at risk for severe disease or death if they contract th ...  Show more